This is the QA environment of the MD-SOAR platform. It is for TESTING PURPOSES ONLY. Navigate to https://mdsoar.org to access the latest open access research from MD-SOAR institutions.
QA Environment
 

“Here it was waiting for me:” Diabetes Diagnosis Pathways and Implications for Health Policy

Date

2022

Department

Program

Citation of Original Publication

Chard, Sarah, et al." "Here it was waiting for me:” Diabetes Diagnosis Pathways and Implications for Health Policy" Journal of Elder Policy 2, no. 2 (Fall 2022): 111-140. https://doi.org/10.18278/jep.2.2.4.

Rights

This item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.
Attribution-Non Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0)

Subjects

Abstract

Diabetes in older adults is a growing public health concern with nearly 30% of Americans 65 and older having diabetes. This includes 2.6 million older adults with undiagnosed diabetes who are at high risk of microvascular and cardiovascular complications (Centers for Disease Control and Prevention, 2022). The majority of cases are Type-2 diabetes. The past decade has witnessed an expansion in screening recommendations in an effort to reduce rates of undiagnosed older adults. Drawing on the sociology of diagnosis, we suggest further attention to the social factors that shape the diagnosis process is needed. We examine the diabetes diagnosis process from the perspective of older adults with type 2 diabetes. The data derive from diabetes illness narrative interviews with non-Hispanic White and African American older adult men and women (age ≥50) with type 2 diabetes (N=83). Our thematic analysis reveals four pathways to diagnosis: 1. Annual wellness exam, 2. Workplace screening, 3. Community-based opportunities, and 4. Health event or alarm. Diabetes’ early symptoms are often normalized within daily life, with health insurance gaps, providers’ dismissal of symptoms, and nonprescription medications reinforcing efforts to address initial symptoms within the home. Wellness visits, as well as worksite and community-based screening, critically intercede in the unfolding of symptoms. In contrast, diagnosis in connection with a health event or alarm carries an additional toll on social and emotional well-being. These findings have implications for national screening policies and local diabetes control efforts.